{"id":145,"date":"2025-12-28T10:49:11","date_gmt":"2025-12-28T10:49:11","guid":{"rendered":"https:\/\/mehmetsalihboga.com\/?page_id=145"},"modified":"2025-12-28T20:59:38","modified_gmt":"2025-12-28T20:59:38","slug":"bobrek-kanseri","status":"publish","type":"page","link":"https:\/\/mehmetsalihboga.com\/index.php\/bobrek-kanseri\/","title":{"rendered":"B\u00f6brek Kanseri"},"content":{"rendered":"\n
\n
\n
\n
\n

B\u00f6brek Kanserleri<\/strong><\/strong><\/p>\n\n\n\n

\n

B\u00fct\u00fcn eri\u015fkin kanser vakalar\u0131n\u0131n yakla\u015f\u0131k %3’\u00fc b\u00f6brek kanserleridir. S\u0131kl\u0131kla 40 ila 70 ya\u015flar\u0131 aras\u0131nda g\u00f6r\u00fcl\u00fcr ve erkeklerde kad\u0131nlara g\u00f6re iki kat daha yayg\u0131nd\u0131r. Her y\u0131l T\u00fcrkiye’de yakla\u015f\u0131k 5000 ki\u015fiye b\u00f6brek kanseri te\u015fhisi konulmaktad\u0131r. D\u00fcnya \u00e7ap\u0131nda oldu\u011fu gibi T\u00fcrkiye’de de b\u00f6brek kanseri vakalar\u0131 art\u0131yor. Bu art\u0131\u015f\u0131n sebebi tam olarak bilinmese de, b\u00f6brek kanseri riskini art\u0131ran baz\u0131 fakt\u00f6rler belirlenmi\u015ftir. Hastal\u0131\u011fa yakalanma olas\u0131l\u0131\u011f\u0131, sigara kullan\u0131m\u0131, \u015fi\u015fmanl\u0131k, y\u00fcksek tansiyon, zararl\u0131 kimyasallara maruz kalmak ve genetik fakt\u00f6rlerden kaynaklanabilir.<\/p>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/figure>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n

Belirtileri<\/strong><\/strong><\/strong><\/strong><\/h2>\n\n\n\n

B\u00f6brek kanserinin standart belirtileri idrardan kan gelmesi, yan a\u011fr\u0131s\u0131 ve ele gelen kitle olarak belirtilmi\u015ftir. Fakat bu semptomlar\u0131 hastalar\u0131n ancak %10-15\u2019lik gibi ufak bir k\u0131sm\u0131 g\u00f6stermektedir. Hastal\u0131k genelde belirti vermeden sinsi bir bi\u00e7imde ilerler fakat son safhalara gelip \u00e7e\u015fitli organlara s\u0131\u00e7rad\u0131\u011f\u0131 takdirde kemik a\u011fr\u0131s\u0131, \u00f6ks\u00fcr\u00fck, sar\u0131l\u0131k, kilo kay\u0131plar\u0131 gibi \u015fikayetlere sebebiyet vermektedir. Erken safhada te\u015fhis koyulan hastalar\u0131n b\u00fcy\u00fck bir k\u0131sm\u0131 ba\u015fka bir sebeple yap\u0131lan radyolojik g\u00f6r\u00fcnt\u00fcleme metotlar\u0131 esnas\u0131nda \u015fans eseri tespit edilmektedir. Erken te\u015fhis konuldu\u011fu takdirde %85\u2019lik gibi bir oranda sa\u011fkal\u0131m sa\u011flanmas\u0131 sebebiyle, \u00f6zellikle aile ya\u015fant\u0131s\u0131nda bulunan ve risk fakt\u00f6r\u00fc ta\u015f\u0131yan \u015fah\u0131slarda d\u00fczenli \u00fcrolojik kontrollerin aksat\u0131lmamas\u0131 \u00f6nerilmektedir.<\/p>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

Tan\u0131 Teknikleri<\/strong><\/strong><\/strong><\/strong><\/strong><\/h2>\n\n\n\n

Hastan\u0131n ge\u00e7mi\u015fi ve \u015fikayetleri hakk\u0131nda doktorun yapaca\u011f\u0131 fiziksel muayene te\u015fhisin ilk a\u015famas\u0131d\u0131r. Bu muayenede, \u00f6zellikle b\u00f6breklerin yerle\u015fti\u011fi kar\u0131n ve yan b\u00f6lgelerde ele gelen kitle veya sertlik olup olmad\u0131\u011f\u0131na bak\u0131l\u0131r. Daha sonraki ara\u015ft\u0131rmalar i\u00e7in hastan\u0131n \u00f6yk\u00fcs\u00fc, hastan\u0131n \u015fikayetleri ve doktorun ilk te\u015fhisi \u00e7ok \u00f6nemlidir. Laboratuvar testleri olarak kan biyokimyas\u0131 ve idrar analizleri, idrarda kanama var m\u0131 yok mu hakk\u0131nda bilgi edinmek i\u00e7in kullan\u0131l\u0131r. G\u00f6r\u00fcnt\u00fcleme y\u00f6ntemlerinin \u00e7o\u011fu b\u00f6brek kanserini tan\u0131mlar. Bu amaca ula\u015fmak i\u00e7in Ultrason (US), Tomografi (BT), MR g\u00f6r\u00fcnt\u00fcleme veya PET\/CT testleri kullan\u0131l\u0131r.<\/p>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
\n

Tedavi<\/strong><\/strong><\/h2>\n\n\n\n

B\u00f6brek t\u00fcm\u00f6rlerinin tedavisinde en yayg\u0131n y\u00f6ntem cerrahi operasyondur. T\u00fcm\u00f6rl\u00fc b\u00f6bre\u011fin tamamen al\u0131nmas\u0131 (radikal nefrektomi) veya yaln\u0131zca t\u00fcm\u00f6rl\u00fc k\u0131sm\u0131n al\u0131nmas\u0131 (parsiyel nefrektomi) ameliyatlar\u0131 yap\u0131labilir. Bu ameliyatlar, t\u00fcm\u00f6r\u00fcn boyutu ve yerle\u015fimine ba\u011fl\u0131d\u0131r. Uygun vakalarda, bu ameliyatlar laparoskopik veya robotik cerrahi ile de ger\u00e7ekle\u015ftirilebilir. Ufak t\u00fcm\u00f6r\u00fc olan m\u00fcsait hastalar i\u00e7in b\u00f6bre\u011fin zarar g\u00f6rmesini \u00f6nleyen ablatif tedaviler (mikrodalga termal ablasyon, radyofrekans ablasyon ve kriyoterapi) kullan\u0131labilir. Bu, b\u00f6breklere zarar vermeden t\u00fcm\u00f6r\u00fc ortadan kald\u0131r\u0131r. Hastal\u0131k ba\u015fka organlara s\u0131\u00e7ram\u0131\u015fsa, ameliyat yerine hedefe y\u00f6nelik tedaviler ve ba\u011f\u0131\u015f\u0131kl\u0131k sistemini uyaran ila\u00e7lar kullan\u0131lmas\u0131 \u00f6nerilir.<\/p>\n<\/div>\n\n\n\n

\n
\"\"<\/figure>\n<\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

B\u00f6brek Kanserleri B\u00fct\u00fcn eri\u015fkin kanser vakalar\u0131n\u0131n yakla\u015f\u0131k %3’\u00fc b\u00f6brek kanserleridir. S\u0131kl\u0131kla 40 ila 70 ya\u015flar\u0131 aras\u0131nda g\u00f6r\u00fcl\u00fcr ve erkeklerde kad\u0131nlara g\u00f6re iki kat daha yayg\u0131nd\u0131r. Her y\u0131l T\u00fcrkiye’de yakla\u015f\u0131k 5000 ki\u015fiye b\u00f6brek kanseri te\u015fhisi konulmaktad\u0131r. D\u00fcnya \u00e7ap\u0131nda oldu\u011fu gibi T\u00fcrkiye’de de b\u00f6brek kanseri vakalar\u0131 art\u0131yor. Bu art\u0131\u015f\u0131n sebebi tam olarak bilinmese de, b\u00f6brek kanseri riskini […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-145","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/mehmetsalihboga.com\/index.php\/wp-json\/wp\/v2\/pages\/145","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mehmetsalihboga.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/mehmetsalihboga.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/mehmetsalihboga.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mehmetsalihboga.com\/index.php\/wp-json\/wp\/v2\/comments?post=145"}],"version-history":[{"count":5,"href":"https:\/\/mehmetsalihboga.com\/index.php\/wp-json\/wp\/v2\/pages\/145\/revisions"}],"predecessor-version":[{"id":224,"href":"https:\/\/mehmetsalihboga.com\/index.php\/wp-json\/wp\/v2\/pages\/145\/revisions\/224"}],"wp:attachment":[{"href":"https:\/\/mehmetsalihboga.com\/index.php\/wp-json\/wp\/v2\/media?parent=145"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}